Expression of Concern to: The α7 nicotine acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function

Ravikumar A Sitapara; Daniel J Antoine; Lokesh Sharma; Vivek S Patel; Charles R Ashby Jr; Samir Gorasiya; Huan Yang; Michelle Zur; Lin L Mantell

doi:10.1186/s10020-020-0143-9

Expression of Concern to: The α7 nicotine acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function

Mol Med. 2020 Feb 3;26(1):16. doi: 10.1186/s10020-020-0143-9.

Authors

Affiliations

¹ Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, USA.
² Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
³ Laboratory of Biomedical Science, Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, New York, USA.
⁴ Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, USA. mantelll@stjohns.edu.
⁵ Center for Inflammation and Immunology, Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, New York, USA. mantelll@stjohns.edu.
⁶ Center for Heart and Lung Research, Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, New York, USA. mantelll@stjohns.edu.

Abstract

The Editors-in-Chief would like to alert readers that this article (Sitapara et al. 2014) is part of an investigation being conducted by the journal following the conclusions of an institutional enquiry at the University of Liverpool with respect to the quantitative mass spectrometry-generated results regarding acetylated and redox-modified HMGB1.

Publication types

Editorial
Expression of Concern